Zaloguj Zarejestruj się zadarmo

Interpace Biosciences Inc organizacji FCF yield

Jaka jest wartość FCF yield organizacji Interpace Biosciences Inc?

Wartość FCF yield organizacji Interpace Biosciences Inc to 41.27%

Jaka jest definicja FCF yield?



Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.

ttm (trailing twelve months)

Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.

Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:

Free cash flow yield = Free cash flow per share / market price per share

FCF yield firm w Health Care sektor na NASDAQ w porównaniu do Interpace Biosciences Inc

Czym się zajmuję organizacja Interpace Biosciences Inc?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Firmy z fcf yield podobne do Interpace Biosciences Inc